跳至主要内容
临床试验/NCT00008749
NCT00008749Unknown不适用

Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus

National Center for Research Resources (NCRR)1 个研究点 分布在 1 个国家开始时间: 2001年1月18日最近更新:
适应症

试验速览

阶段
不适用
发起方
试验地点
1

研究概览

简要总结

Systemic lupus erythematosus is an often devastating autoimmune disease which affects 1 in 2,000 women in the United States. Recently, several research laboratories have reported that a protein, named CD40-ligand (CD154), is overexpressed by a subset of white blood cells, called lymphocytes, in patients with lupus. Expression of CD154 appears critical to the generation of antibodies that cause disease in lupus. Blocking CD154 interactions in the immune system has been shown to decrease disease activity in animal models of lupus. We propose to study the regulation of CD154 in patients with lupus in hopes of inhibiting its abnormal and deleterious expression.

研究设计

研究类型
Observational
观察模型
Case Control

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
National Center for Research Resources (NCRR)
申办方类型
Nih

研究点 (1)

Loading locations...

相似试验